Advanced search
Publication Cover
Future Oncology Volume 15, 2019 - Issue 34
Submit an article Journal homepage
241
Views
2
CrossRef citations to date
0
Altmetric
Drug Evaluation

Quizartinib in the Treatment of FLT3-Internal-Tandem Duplication-Positive Acute Myeloid Leukemia

Shilpa Paul1 Department of Clinical Pharmacy, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0377, Houston, TX77030, USA
,
Adam J DiPippo1 Department of Clinical Pharmacy, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0377, Houston, TX77030, USA
,
Farhad Ravandi2 Department of Leukemia, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0428Houston, TX77030, USA
&
Tapan M Kadia2 Department of Leukemia, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0428Houston, TX77030, USACorrespondence[email protected]
Pages 3885-3894 | Received 22 Jun 2019, Accepted 13 Sep 2019, Published online: 27 Sep 2019

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Felicetto Ferrara & Alessandra Picardi. (2020) Is outcome of older people with acute myeloid leukemia improving with new therapeutic approaches and stem cell transplantation?. Expert Review of Hematology 13:2, pages 99-108.
Read now

Articles from other publishers (1)

Jayastu Senapati & Tapan Mahendra Kadia. (2022) Which FLT3 Inhibitor for Treatment of AML?. Current Treatment Options in Oncology 23:3, pages 359-380.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.